After a decade in clinical research and data analysis, helping bring drugs to market, we are proud to share our statistical consulting expertise with our valued partners. Whatever the stage and scale of your proposed study, we provide statistical assistance to help get the most out of your clinical data while maintaining regulatory compliance. We ensure our operations are up to date across a variety of different regulations, including 21CFR, ICH GCP, US-FDA, UK/NICE SI, EU CTR, and more. High rates of internal retention and job satisfaction mean we can bring our clients the best insights and statistical approaches.
Intego Clinical provides assistance with protocol writing, population assessment, statistical considerations, statistical analysis plans and maintenance of studies from the statistical point of view. Regardless of the scale or complexity of your clinical trial program, our support will help you meet your goals.
We’ve been an industry leader for over a decade, thanks to excellent staff retention and our commitment to ongoing professional training. Our expertise allows us to facilitate the most effective and efficient clinical trials for clients, regardless of the regulatory framework they work within.
New advances in data science technology enable pharma companies and CROs to get more out of their clinical trial data than ever before. Intego Clinical is a leader in this field, and has developed proprietary platforms to find hidden data patterns and insights within our client’s study data. Our team has expertise in Python, R, R Shiny and SAS, and our clinical data mining technology incorporates state-of-the-art machine learning algorithms, statistical tools, and data visualization libraries.
Our team operates as an extension of your global network, seamlessly integrating with distributed teams from Eastern/Western US, UK, China, India, and other regions across the globe. Intego’s extensive knowledge and adherence to industry best practices ensures we always produce high-quality deliverables on time and under budget: